59.57
-0.92
(-1.52%)
At close: January 13 at 3:57:29 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
1,388,000.00
1,388,000.00
1,020,000.00
1,217,000.00
1,130,000.00
Investing Cash Flow
-1,096,000.00
-1,096,000.00
-974,000.00
1,021,000.00
-1,089,000.00
Financing Cash Flow
-152,000.00
-152,000.00
-284,000.00
-1,283,000.00
93,000.00
End Cash Position
1,468,000.00
1,468,000.00
1,339,000.00
1,582,000.00
495,000.00
Capital Expenditure
-1,682,000.00
-1,682,000.00
-1,872,000.00
-1,341,000.00
-973,000.00
Issuance of Capital Stock
9,000.00
9,000.00
7,000.00
--
--
Issuance of Debt
1,348,000.00
1,348,000.00
--
--
974,000.00
Repayment of Debt
-655,000.00
-655,000.00
-152,000.00
-1,201,000.00
-820,000.00
Repurchase of Capital Stock
-1,020,000.00
-1,020,000.00
-58,000.00
-174,000.00
-141,000.00
Free Cash Flow
-294,000.00
-294,000.00
-852,000.00
-124,000.00
157,000.00
12/31/2020 - 1/20/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
EZB.BE Enzo Biochem Inc
0.6300
-2.33%
NN6.F NanoRepro AG
1.4200
-4.05%
01P.F Medpace Holdings, Inc.
341.00
-0.55%
IDHCl.XC
ESF0.MU Eurofins Scientific SE
50.22
0.00%
MVF.AX Monash IVF Group Limited
1.2150
+0.83%
VIMIAN.ST Vimian Group AB (publ)
38.35
+2.68%
DAP.DE Danaher Corporation
237.95
+1.21%
PRM.L Proteome Sciences plc
3.6200
-14.82%
SZLS.TO StageZero Life Sciences Ltd.
0.0400
0.00%